Fig. 1: Immunostaining characterizes disulfidptosis in COAD, LUAD, LUSC, KICH, and LIHC patients. | npj Precision Oncology

Fig. 1: Immunostaining characterizes disulfidptosis in COAD, LUAD, LUSC, KICH, and LIHC patients.

From: Pan-cancer analysis uncovered the prognostic and therapeutic value of disulfidptosis

Fig. 1

Representative immunofluorescence staining of (A) SLC7A11 and ACTB in tumor tissue and normal tissue and (B) GLUT1 and SLC7A11 in tumor tissue (n = 3). Scale bars represent 100 μm. Quantification of SLC7A11 in (C) tumor and normal tissue and (D) tumor of high and low GLUT1 expression. COAD Colon Cancer, LUAD Lung Adenocarcinoma, LUSC Lung Squamous Cell Carcinoma, KICH Kidney Chromophobe, LIHC Liver Cancer.

Back to article page